King Hussein Cancer Center holds its 2nd Joint Conference Update on Genitourinary Malignancies 2013 in partnership with the AUB and MDACC
- Jordan: Thursday, January 31 - 2013 at 13:26
- PRESS RELEASE
HRH Princess Ghida Talal, Chairperson of the Board of Trustees of King Hussein Cancer Foundation (KHCF), inaugurated on the 31 January 2013, the 2nd Joint Conference KHCC/ AUB/ MDACC entitled "Update on Genitourinary Malignancies 2013", in presence of HRH Princess Dina Mired, Director General of the King Hussein Cancer Foundation.
During the opening ceremony HRH Princess Ghida Talal welcomed the participants while stressing on the importance of such "Twinning" partnership that adds to the achievements of the King Hussein Cancer Center. She praised the progress achieved by Jordan, and the center in particular in the field of treatment of genitourinary malignancies.
Dr. Naim Farah, Chairman of the Conference and Chairman, Unit of Kidney surgery and Urinary Tract at King Hussein Cancer Center, said the first conference was held in Beirut as part of the cooperation between the three institutions associated with a twinning partnership as a result of the close cooperation that brings them together in many common areas such as: training, education, organization of joint scientific activities, exchange of experiences and joint research projects.
Dr. Farah added that this conference is held on annual basis in order to keep up with the latest findings of science in the diagnosis and treatment of the genitourinary malignancies.
He pointed out more than 150 doctors in the fields of surgery, clinical oncology, surgery genitourinary malignancies and therapeutic radiology, both Arab and international who are participating in the conference. Experts, consultants, researchers, and specialists from the United States of America, Lebanon and Jordan are expected to discuss the different aspects of genitourinary malignancies diagnosis, treatment and related approaches.
Dr. Faisal Al Badainh, Chairman of the Conference's Scientific Committee and Consultant Oncology in KHCC said that according to the National Cancer Registry in Jordan for the year 2009, around (206) new cases were diagnosed with urinary bladder cancer about (4.3%) out of all newly registered cancer cases. Malignant cancer of the urinary bladder accounted for (68.4%) of all urinary tract cancers in Jordan.
Dr. Al Badainh explained that bladder cancer is more frequent in males than in females as it is the 5th common cancer in males having affected (184) males (89.3%) while only (22) females were affected with bladder cancer each year with (10.7%). This means that the proportion of bladder cancer in males to females is (8.3:1) compared to (6.3:1) in 2008. He also added that bladder cancer incidence age for both sexes was 65 years.
On the other hand in (2009), there were (179) cases of prostate cancer accounting (3.7%) of all cancer cases. It ranked 6th among common cancers in males and accounted (7.9%) of male cancers. The prostate cancer increases with age. He confirmed that (75%) of prostate cancer cases occur at the age of ( 65) years and above, while the incidence age for diagnosis with prostate cancer reached (70) years.
According to Dr. Badainh the kidney and testicular cancers are less common than the bladder and prostate cancers.
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / 4C. AME Info FZ LLC / 4C is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.